Left ventricular assist device implantation and clinical outcomes in the Netherlands.
Kevin DammanKadir CaliskanOzcan BirimMichiel KuijpersLuuk C OtterspoorAria YazdanbakhshMeindert PalmenFaiz Z RamjankhanLauren F TopsLinda W van Laakenull nullPublished in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2023)
Long-term survival on durable LVAD support in the Netherlands is over 50% after 5 years. Major adverse events, especially infection and bleeding, are still frequently observed, but decreasing with the contemporary use of HeartMate 3 LVAD.